Windlas Biotech Limited (NSE:WINDLAS)
India
· Delayed Price · Currency is INR 971.00
+14.80 (1.55%)
May 22, 2025, 3:29 PM IST
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 19.98 billion as of May 22, 2025. Its market cap has increased by 74.50% in one year.
Market Cap
19.98B
Enterprise Value
18.04B
Revenue
7.28B
Ranking
n/a
PE Ratio
32.66
Stock Price
971.00
Market Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 19.98B, an increase of 125.22%. That is a compound annual growth rate of 24.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2025 | 19.98B | -8.16% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,155.17B |
| Divi's Laboratories | 1,739.35B |
| Cipla | 1,197.25B |
| Mankind Pharma | 1,044.64B |
| Apollo Hospitals Enterprise | 1,004.19B |
| Zydus Lifesciences | 895.20B |
| Aurobindo Pharma | 699.34B |
| Alkem Laboratories | 642.54B |